Oppenheimer Maintains Outperform on Insulet, Raises Price Target to $324

Benzinga · 3d ago
Oppenheimer analyst Steven Lichtman maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $312 to $324.